Previously recorded as Ena Therapeutics Pty Ltd. (to 2022)
One patent currently held, every record listed here
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2039. from the record
Of the 5 now held by other companies, 4 name Ena Respiratory Pty Ltd. as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2039
Next term end
1
Patent families
When these terms end
Each bar runs from grant to computed term end. 2017 to 2040.20222027203220372040
3 pending applications: term is not computable until grant.Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Oct 2031 · High confidence
The most cited patent in this portfolio, cited by 13 later US patents, top 25% of utility patents granted in 2017 in our data. Protection runs to 2031.
now held by Ena Respiratory Pty Ltd.
Also notable
Ends Apr 2029 · Medium confidence
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2029.
now held by Ena Respiratory Pty Ltd.
Also notable
Ends Aug 2040 · Medium confidence
Granted 2026. Too new for citation comparison; protection runs to 2040. A terminal disclaimer caps this term to an earlier patent's.
now held by Ena Respiratory Pty Ltd.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Optimised Compounds | 1 in force | to Sep 2039 |
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,195,557 | Optimised Compounds In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 5 patents in force now held by others · 3 applications pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.